Search research articles
Contact Us
Filters
Showing results (61-70 of 67) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 67 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2025
Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas
Jason J Luke, Randy F Sweis, J Randolph Hecht, et al.
Nucleic Acids Research
|
September 28, 2004
Amplification and assembly of chip-eluted DNA (AACED): a method for high-throughput gene synthesis
Kathryn E Richmond, Mo-Huang Li, Matthew J Rodesch, et al.
Current Microbiology
|
October 7, 2024
Acinetobacter corruptisaponis sp. nov., Isolated from a Spoiled Bath Lotion
Ying-Si Wang, Gang Zhou, Hong-Bing Tao, et al.
Blood Advances
|
December 31, 2021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
Gareth P Gregory, Shaji Kumar, Ding Wang, et al.
Cell Reports
|
April 5, 2018
Systematic Analysis of Splice-Site-Creating Mutations in Cancer
Reyka G Jayasinghe, Song Cao, Qingsong Gao, et al.
Lancet (London, England)
|
January 21, 2024
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Jeffrey S Weber, Matteo S Carlino, Adnan Khattak, et al.
Molecular Cancer
|
December 14, 2023
Dynamic altruistic cooperation within breast tumors
Muhammad Sufyan Bin Masroni, Kee Wah Lee, Victor Kwan Min Lee, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 67) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 67 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2025
Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas
Jason J Luke, Randy F Sweis, J Randolph Hecht, et al.
Nucleic Acids Research
|
September 28, 2004
Amplification and assembly of chip-eluted DNA (AACED): a method for high-throughput gene synthesis
Kathryn E Richmond, Mo-Huang Li, Matthew J Rodesch, et al.
Current Microbiology
|
October 7, 2024
Acinetobacter corruptisaponis sp. nov., Isolated from a Spoiled Bath Lotion
Ying-Si Wang, Gang Zhou, Hong-Bing Tao, et al.
Blood Advances
|
December 31, 2021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
Gareth P Gregory, Shaji Kumar, Ding Wang, et al.
Cell Reports
|
April 5, 2018
Systematic Analysis of Splice-Site-Creating Mutations in Cancer
Reyka G Jayasinghe, Song Cao, Qingsong Gao, et al.
Lancet (London, England)
|
January 21, 2024
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Jeffrey S Weber, Matteo S Carlino, Adnan Khattak, et al.
Molecular Cancer
|
December 14, 2023
Dynamic altruistic cooperation within breast tumors
Muhammad Sufyan Bin Masroni, Kee Wah Lee, Victor Kwan Min Lee, et al.
Page
of 7